• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Matthew D. Pierson, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Matthew Pierson, MD, Assistant Professor (Clinical), earned his medical degree at the University of North Carolina at Chapel Hill (UNC). He completed psychiatry residency and child and adolescent psychiatry fellowship at Duke University, where he served as chief resident during his fellowship training. While at Duke, Dr. Pierson gave frequent lectures to medical students, residents, and community clinicians on child and adolescent psychiatry. He also participated in conducting clinical trials research in brain stimulation technologies including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and magnetic seizure therapy (MST). Since joining the School of Medicine faculty at the University of Utah, Dr. Pierson has continued to provide clinical education and supervision to trainees. In 2016, he received the Award for Clinical Supervision from the University of Utah Child and Adolescent Psychiatry Fellowship Program. Dr. Pierson is board-certified by the American Board of Psychiatry and Neurology (ABPN) in Psychiatry as well as Child and Adolescent Psychiatry and he is an active member of the American Academy of Child and Adolescent Psychiatry. His areas of expertise include evaluating youth with complex psychiatric conditions, caring for patients with severe mood disorders, and providing clinical supervision to trainees. His research interest is in treatment-resistant mood disorders.

Dr. Pierson is active in several clinical services as a child and adolescent inpatient psychiatrist at the University of Utah Huntsman Mental Health Institute. Here he treats hospitalized youth, ages 4-17, with a variety of psychiatric conditions. Dr. Pierson is the co-Medical Director of the Comprehensive Assessment and Treatment (CAT) Program. Additionally, he treats adults and youth in the Treatment-Resistant Mood Disorders (TRMD) clinic, where he administers electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine infusions.

Clinical Locations

Huntsman Mental Health Institute (formerly UNI)

801-583-2500

501 Chipeta Way
Salt Lake City, UT  84108
Map

Specialties

  • Psychiatry, Child & Adolescent
  • Psychiatry, Child
  • Child & Adolescent Behavioral Health
  • Mood Disorders
  • Psychiatry

Board Certification and Academic Information

Academic Departments Psychiatry - Assistant Professor (Clinical)
Academic Divisions Child Psychiatry
Board Certification American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry)
American Board of Psychiatry & Neurology (Psychiatry)

Matthew Pierson, MD, Assistant Professor (Clinical), earned his medical degree at the University of North Carolina at Chapel Hill (UNC). He completed psychiatry residency and child and adolescent psychiatry fellowship at Duke University, where he served as chief resident during his fellowship training. While at Duke, Dr. Pierson gave frequent lectures to medical students, residents, and community clinicians on child and adolescent psychiatry. He also participated in conducting clinical trials research in brain stimulation technologies including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and magnetic seizure therapy (MST). Since joining the School of Medicine faculty at the University of Utah, Dr. Pierson has continued to provide clinical education and supervision to trainees. In 2016, he received the Award for Clinical Supervision from the University of Utah Child and Adolescent Psychiatry Fellowship Program. Dr. Pierson is board-certified by the American Board of Psychiatry and Neurology (ABPN) in Psychiatry as well as Child and Adolescent Psychiatry and he is an active member of the American Academy of Child and Adolescent Psychiatry. His areas of expertise include evaluating youth with complex psychiatric conditions, caring for patients with severe mood disorders, and providing clinical supervision to trainees. His research interest is in treatment-resistant mood disorders.

Dr. Pierson is active in several clinical services as a child and adolescent inpatient psychiatrist at the University of Utah Huntsman Mental Health Institute. Here he treats hospitalized youth, ages 4-17, with a variety of psychiatric conditions. Dr. Pierson is the co-Medical Director of the Comprehensive Assessment and Treatment (CAT) Program. Additionally, he treats adults and youth in the Treatment-Resistant Mood Disorders (TRMD) clinic, where he administers electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine infusions.

Academic Locations

Research Statement

Dr. Matthew Pierson is an Assistant Professor (Clinical) of Psychiatry at the University of Utah, where he is active in several clinical services. He is a child and adolescent inpatient psychiatrist at the University of Utah Neuropsychiatric Institute (UNI). Here he treats hospitalized youth, ages 4-17, with a variety of psychiatric conditions. Dr. Pierson is also the co-Medical Director of the Comprehensive Assessment and Treatment (CAT) Program at UNI. He also treats adults and youth in the Treatment-Resistant Mood Disorders (TRMD) clinic.

Dr. Pierson's areas of experise include evaluating youth with complex psychiatric conditions, caring for patients with severe mood disorders, and providing clinical supervision to trainees. Through the TRMD clinic, Dr. Pierson administers electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine infusions. Dr. Pierson has been the recipient of the Award for Clinical Supervision by the University of Utah Child and Adolescent Psychiatry Fellowship Program.

Board Certification and Academic Information

Academic Departments Psychiatry - Assistant Professor (Clinical)
Academic Divisions Child Psychiatry
Board Certification American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry)
American Board of Psychiatry & Neurology (Psychiatry)

Education History

Residency Duke University Medical Center
General Psychiatry
Resident, 2014
Chief Resident Duke University Medical Center
Child and Adolescent Psychiatry Fellowship
Chief Resident, 2013
Fellowship Duke University Medical Center
Child and Adolescent Psychiatry
Fellow, 2013
Professional Medical University of North Carolina School of Medicine
Medicine
M.D., 2009
Graduate Training University of North Carolina at Greensboro
Premedical Program
Postbaccalaureate Studies, 2004
Undergraduate University of Virginia
Religious Studies, Minor in Architecture
B.A., 2002

Selected Publications - Journal Articles

Journal Article

  1. Pierson MD, Mickey BJ, Gilley LB, Weeks HR (2021). Outcomes of Youth Treated with Electroconvulsive Therapy: A Retrospective Cohort Study. J Clin Psychiatry.
  2. Mickey BJ, White AT, Arp AM, Leonardi K, Torres MM, Larson AL, Odell DH, Whittingham SA, Beck MM, Jessop JE, Sakata DJ, Bushnell LA, Pierson MD, Solzbacher D, Kendrick EJ, Weeks HR 3rd, Light AR, Light KC, Tadler SC (2018). Propofol for Treatment-Resistant Depression: A Pilot Study. Int J Neuropsychopharmacol, 21(12), 1079-1089.
  3. Pierson MD, Muzyk AJ, Lockamy M, Preudhomme XA (2010). Topiramate-induced confusion following a single ingestion of 400 mg. Gen Hosp Psychiatry, 32(6), 647.e1-3.

Patient Stories

ECT Provides Hope for Husband and Father Struggling with Bipolar Disorder

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health